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Predictors for adverse outcome after iliac
angioplasty and stenting for limb-threatening
ischemia
Carlos H. Timaran, MD, Scott L. Stevens, MD, Michael B. Freeman, MD, and Mitchell H. Goldman,
MD, Knoxville, Tenn
Objective: The role of iliac artery angioplasty and stenting (IAS) for the treatment of limb-threatening ischemia is not
defined. IAS has been used primarily for patients with disabling claudication. Because poorer results have been shown in
patients with critical ischemia after iliac artery angioplasty, the purpose of this study was to estimate the influence of risk
factors on the outcome of iliac angioplasty and stent placement in patients with limb-threatening ischemia.
Methods: During a 5-year period (from 1996 to 2001), 85 iliac angioplasty and stent placement procedures (107 stents)
were performed in 31 women and 43 men with limb-threatening ischemia. Patients with claudication were specifically
excluded. The criteria prepared by the Ad Hoc Committee on Reporting Standards (Society for Vascular Surgery/
International Society for Cardiovascular Surgery) were followed to define the variables. The TransAtlantic InterSociety
Consensus classification was used to characterize the type of iliac lesions. Both univariate (Kaplan-Meier [KM]) and
multivariate analyses (Cox proportional hazards model) were used to determine the association between variables,
cumulative patency, limb salvage, and survival.
Results: Indications for iliac angioplasty with stenting were ischemic rest pain (56%) and tissue loss (44%). Primary
stenting was performed in 36 patients (42%). Stents were placed selectively after iliac angioplasty mainly for residual
stenosis or pressure gradient (43%). Overall, primary stent patency rate was 90% at 1 year, 74% at 3 years, and 69% at 5
years. Primary stent patency rate was significantly reduced in women compared with men (KM, log-rank test, P < .001).
Primary patency rates at 1, 3, and 5 years were 79%, 57%, and 38% for women and 92%, 88%, and 88% for men. Primary
stent patency rate also was significantly reduced in patients with renal insufficiency (creatinine level, >1.6 mg/dL; KM,
log-rank test, P < .001). Cox regression analysis identified female gender (relative risk, 5.1; 95% CI, 1.8 to 7.9; P .002)
and renal insufficiency (relative risk, 6.6; 95% CI, 1.6 to 14.2; P  .01) as independent predictors of decreased primary
stent patency. No independent predictors for limb salvage and survival were identified.
Conclusion: Women undergoing iliac angioplasty and stenting for limb-threatening ischemia have significantly reduced
primary stent patency rates and may need additional procedures to obtain satisfactory clinical improvement and limb
salvage. Patients with renal insufficiency and critical ischemia also have reduced primary stent patency rates after IAS.
Limb salvage, as shown in this study, is not affected by previous iliac stent failure. (J Vasc Surg 2002;36:507-13.)
Iliac artery angioplasty is regarded as an standard treat-
ment of aortoiliac occlusive disease, primarily for more focal
lesions in patients with disabling claudication.1,2 Risk fac-
tors for poor primary patency after iliac artery angioplasty
are associated with the indication, lesion severity, runoff,
patient gender, and anatomic location of the lesion.1-3
Johnston et al1,2 have identified consistently the indication
or clinical stage of the patient (claudication versus limb-
threatening ischemia [LTI]) as a significant predictor of
outcome after iliac angioplasty alone. Poorer results were
shown in patients with LTI.
Stent placement after iliac artery angioplasty has been
used to improve the initial technical success rate and de-
crease the risk of long-term failure.4-8 Several observational
studies have attempted to identify risk factors for success
after placement of iliac stents. Laborde et al9 showed ad-
verse results in patients with LTI.However, most authors
have found no significant differences in outcome when
stratified to clinical stage.6,7
Most series on iliac stenting have included patients with
different grades of ischemia but primarily used patients with
disabling claudication.4-8,10 Because only a few reports
have focused on the use of iliac angioplasty for the treat-
ment of LTI, less is known about the effects of iliac stenting
in these patients.11,12 We recently reported the influence of
the anatomic location and patient gender on the outcome
of iliac artery angioplasty and stenting in patients with both
disabling claudication and critical ischemia.13 In this previ-
ous study, external iliac artery (EIA) angioplasty and female
gender were identified as independent predictors of poor
outcome. To determine whether the previously identified
independent predictors also influence the outcome of iliac
angioplasty and stenting in patients with chronic critical
ischemia, only patients with LTI were included in this
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study. This series represents our more recent experience
and current approach with most iliac angioplasty and stent-
ing procedures performed in the operating room by vascu-
lar surgeons.
To assess the outcome of patients undergoing iliac
artery angioplasty and stent placement for LTI, defined
preoperative, procedural, and artery-specific factors were
investigated as predictors of adverse results. The most
current recommendations and standards were used to de-
fine the different variables.14-16 The effect of anatomic
stenting location (ie, EIA versus common iliac artery
[CIA]) and patient gender, in particular, on stent patency
were analyzed considering only patients with LTI.
METHODS
Between July 1996 and July 2001, 85 consecutive iliac
angioplasty and stent placement procedures (107 stents in
total) were performed in 31 women and 43 men with LTI
at the University of Tennessee Medical Center at Knoxville,
and all were included in a cohort study. All the patients had
evidence of chronic critical limb ischemia. Patients with
claudication were specifically excluded. Demographic data,
risk factors, complications, and outcome variables were
defined according to the criteria prepared and revised by
the Ad Hoc Committee on Reporting Standards (Society
for Vascular Surgery/International Society for Cardiovas-
cular Surgery [SVS/ISCVS]).15,16 Patients who had un-
dergone a previous iliac angioplasty or stenting were not
included. Preoperative, intraoperative, and follow-up infor-
mation was available in all patients and was obtained via
office and hospital chart review, dictated operative records,
and telephone conversations with patients, physicians, or
family members. The local institutional review board ap-
proved the study protocol.
Most procedures were performed in the operating
room by vascular surgeons. Intraoperative arteriography
was performed with an ipsilateral or contralateral femoral
approach. Bilateral femoral approach was used frequently
for patients needing bilateral stent placement. Stents were
placed through 7F or 8F sheaths. Most procedures were
performed with a self-expandable Wallstent (Boston Scien-
tific Vascular, Boston, Mass) that was usually placed for
long-segment disease or tortuous iliac arteries and for con-
tralateral approaches. A balloon-expandable Palmaz stent
(Cordis J and J, Warren, NJ) was used preferentially for
focal lesions and severely calcified lesions and for all lesions
adjacent to the aortic bifurcation. A stent placement was
deemed technically successful if there was a 30% residual
stenosis and if the gradient across the treated lesion was less
than 5 mm Hg. There was no strict postoperative surveil-
lance protocol. However, the patients were usually seen
within 2 weeks from the time of the procedure. Improve-
ment and changes in clinical status were determined with
history and noninvasive vascular laboratory tests. At the
discretion of the attending surgeon, postoperative fol-
low-up (clinical and serial duplex ultrasound scanning ex-
aminations) was conducted every 3 months during the first
postoperative year and every 6 months thereafter. Arteriog-
raphy was performed when duplex scanning revealed a
decrease in ankle/brachial index of 0.15 or more or if peak
systolic velocities were greater than 300 cm/s. Indications
for reintervention included a stenosis60% and a gradient
across the lesion greater than 15 mm Hg with papaverine
hydrochloride or greater than 10 mm Hg at rest. All
revisions performed on the basis of these criteria or occlu-
sion were considered a stent failure and an end of primary
patency.15
The recently developed TransAtlantic Intersociety
Consensus (TASC) classification of disease severity for iliac
lesions was used to define the categories of the lesions
(Table I).14 Runoff was classified from review of both
preoperative and intraoperative arteriograms (Ad Hoc
Committee on Reporting standards, SVS/ISCVS).15,16
Runoff was assessed in the common femoral artery, super-
ficial femoral artery, and deep femoral artery. The angio-
graphic runoff score was further used for subgroup analysis,
categorizing scores as poor runoff (score equal or higher
than 5) and good runoff (score less than 5). Patients with
superficial femoral artery occlusion and angiographic runoff
score greater than 5 usually received a simultaneous infrain-
guinal reconstruction. Vessel size was determined accord-
ing to the maximum balloon size used for dilatation and
measurements of lumen diameter above or below the lesion
that were obtained from arteriography.
Power analysis was performed on the data set to deter-
mine the  error and was based on our previous study. A
35% difference in 5-year primary stent patency rates be-
tween patient subgroups (relative risk [RR], 2.5) allowed
an 82% power of detection of such difference with a two-
sided type I error rate of 0.05.
All analyses were performed according to the intention-
to-treat principle. Univariate analysis of categoric variables
was performed with Fisher exact test or 2 with Yates
correction, as indicated (2 for contingency tables, two-
tailed P value). Student t test and nonparametric tests
(Mann–WhitneyU test) were used to compare continuous
variables. Primary angioplasty stent patency, limb salvage,
and patient survival rates were determined with the Kaplan-
Table I. TASC morphologic stratification of iliac lesions
Type
A Single stenosis of CIA or EIA  3 cm in length (unilateral
or bilateral)
B Single stenosis 3 to 10 cm in length not extening into CFA
Two stenosis of CIA or EIA not involving CFA  5 cm
Unilateral CIA occlusion
C Bilateral stenoses of CIA or EIA not involving CFA of 5 to
10 cm in length
Unilateral EIA occlusion not involving CFA
Unilateral EIA stenosis extending into CFA
Bilateral CIA occlusion
D Diffuse stenosis of entire CIA, EIA, and CFA of  10 cm
Unilateral occlusion of CIA and EIA
Bilateral EIA occlusions
Iliac stenosis adjacent to aortic or iliac aneurysms
CFA, Common femoral artery.
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Meier (KM) method and the log-rank test.17 Cox propor-
tional hazards model was used for multivariate analyses to
assess the influence of various risk factors on stent paten-
cy.18,19 Variables that had a P value less than .25 in the
univariate analysis and possible confounding factors were
entered into the regression model and considered signifi-
cant with forward stepwise selection if P was less than .05.
For statistical analyses, SPSS for Windows version 10.0
(SPSS Inc, Chicago, Ill) was used.20
RESULTS
The median patient age was 60 years (range, 39 to 83
years). The most commonly associated risk factors in the
overall group were a significant history of tobacco use
(80%), hypertension (79%), coronary artery disease (75%),
hyperlipidemia (61%), and diabetes mellitus (39%). Indica-
tions for the procedures were ischemic rest pain in 48
patients (56%) and tissue loss in 37 (44%). The median
follow-up period was 29 months, with a range from 4 to 62
months. The median preoperative ankle-brachial index at
rest was 0.38, which increased after surgery to 0.89.
Most procedures were performed percutaneously
(67%) with local anesthesia (62%) in the operating room
(82%). Wallstents were used in 52 procedures (61%),
Palmaz stents in 23 (27%), and a combination of both in 10
(12%). Single stents were used in 51 lesions (60%), two
stents in 28 (33%), and three stents in six (7%). Primary
stenting was performed in 36 patients (42%). Selective
stenting was performed for the following indications: a
residual stenosis or pressure gradient after angioplasty
(43%), a dissection after balloon angioplasty (7%), an ec-
centric lesion (5%), or a long segment occlusion (3%).
Forty-nine angioplasty and stenting procedures (58%) were
performed for CIA lesions and 36 (42%) for EIA lesions.
Thirty patients had both CIA and EIA stents placed. Stents
were placed in 15 TASC type A iliac lesions (18%), 42 type
B lesions (49%), 26 type C lesions (31%), and two (2%) type
D lesions. The median preoperative pressure gradient
across the iliac lesions before balloon angioplasty was 35
mm Hg (range, 10 to 95 mm Hg).
Initial technical success was obtained in 82 procedures
(96%). Initial hemodynamic success and clinical improve-
ment, as defined by the SVS/ISCVS reporting standards,
was obtained in 93% of patients. Thirty-three percent of
patients had improvement to category3, 45% to category
2, and 12% to category1. Three percent of patients had
unchanged conditions, whereas 4% of patients had wors-
ened conditions (category 1, 2%; category 2, 1%; cate-
gory 3, 1%). Thirty-five additional concomitant surgical
procedures were performed: 28 infrainguinal bypass grafts,
five femorofemoral bypass grafts, and two superficial fem-
oral artery angioplasties. Twelve subsequent infrainguinal
arterial reconstructions were performed at a median of 13
months after the initial iliac angioplasty and stenting. There
were six vascular complications: four arterial dissections and
two femoral pseudoaneurysms. One dissection necessitated
surgical intervention, as did one pseudoaneurysm; all theses
patients underwent aortobifemoral bypass and were consid-
ered to have stent failures. Neither stent infection nor distal
embolization occurred. Twelve patients underwent a sur-
gical reconstruction (seven aortobifemoral, three iliofemo-
ral, and two femorofemoral bypass grafts) at a median of
8.0 months after iliac angioplasty and stenting. Among
patients who underwent additional infrainguinal arterial
reconstructions, 13 (32%) had focal flow abnormalities on
duplex surveillance scans (peak systolic velocity, 150
cm/s; velocity ratio, 1.5) with moderate and severe graft
stenoses confirmed with angiography and reintervention.
Concomitant iliac stent stenosis or occlusion was not
shown in any of these patients. Infrainguinal bypass graft
occlusions as the result of iliac stent failure did not occur.
Forty-six iliac angioplasty and stenting procedures
(54%) were performed in 43 men, and 39 (46%) in 31
women. Compared with men, women were significantly
older (P .003) and had a higher frequency of hyperlipid-
emia (84% versus 41%; P  .001). Conversely, hyperten-
sion was more frequent in men (89% versus 67%; P .02).
No other significant differences were noted with univariate
analysis with regard to patient risk factors (Table II). There
were also several differences in the frequency and distribu-
tion of the characteristics of the iliac lesions between men
and women. Iliac artery occlusive disease tended to be more
extensive and multifocal with more TASC type C and D
lesions in women (46% versus 22%; P  .03) when com-
pared with men. Primary stent placement was more fre-
quently used in women (Table II). Runoff scores were also
higher in women. The average vessel size or artery diame-
ter, on the basis of the maximum balloon size used for
dilatation, of the CIA in women was significantly smaller
than that of the CIA in men (7.4  0.9 mm versus 8.4 
1.1 mm, respectively; P .002). However, the average size
of the EIA between women and men was not significantly
different (6.5  1.7 mm versus 7.0  0.9 mm, respective-
ly). There were no differences between men and women
with respect to type of stent used, anatomic location of
Table II. Clinical characteristics of women and men
undergoing iliac angioplasty and stenting for
limb-threatening ischemia
Women
(n  31)
Men
(n  43) P value
Median age (y) 65 58 .003*
Comorbidities
Diabetes mellitus 13 (41%) 16 (37%) NS
Hypertension 21 (67%) 38 (89%) .02†
Smoking 28 (77%) 36 (83%) NS
Coronary artery disease 26 (85%) 29 (67%) NS
Hyperlipidemia 26 (85%) 18 (41%) .001†
Renal insufficiency (creatinine
level  1.6 mg/dL)
3 (10%) 1 (2%) NS
Indications
Rest pain 16 (51%) 26 (61%) NS
Tissue loss 15 (49%) 17 (39%) NS
*Mann-Whitney U test.
†2 analysis.
NS, Not significant.
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stenting, type of lesion (stenosis versus occlusion), patency
of the ipsilateral superficial femoral artery, or number of
concomitant outflow procedures (Table III).
Cumulative primary patency rates for all patients at 1, 3,
and 5 years were 90%, 74%, and 69%, respectively. Primary
patency rates in women at 1, 3, and 5 years were 79%, 57%,
and 38%, respectively. Primary patency rates in men at 1, 3,
and 5 years were 92%, 88%, and 88%, respectively. Women
had significantly decreased primary stent patency rates
compared with men with univariate analysis (Fig; KM,
log-rank test, P  .0001). Stratified analyses revealed that
women who had EIA stents had the poorest outcome;
primary patency rates for these patients at 1, 3, and 5 years
were 83%, 59%, and 29%, respectively, whereas for women
with CIA stents such rates were 76%, 54%, and 54%. Pri-
mary patency rates were also significantly different for other
variables analyzed. Primary stent patency was significantly
reduced in patients with renal disease (creatinine level, 
1.6 mg/dL) compared with patients with normal renal
function (KM, log-rank test, P  .0001). Primary patency
rates at 1, 3, and 5 years were 75%, 55%, and 25% for
patients with renal insufficiency and 94%, 76%, and 71% for
patients with normal renal function. Primary stent patency
rate for smokers also was significantly reduced compared
with nonsmokers (KM, log-rank test, P  .04). Moreover,
primary patency rates were significantly decreased in pa-
tients with hyperlipidemia (KM, log-rank test, P  .001)
and lesions with poor runoff (score,5; KM, log-rank test,
P  .001). Primary stent patency rates were not signifi-
cantly different for other risk factors analyzed, including the
use of concomitant infrainguinal arterial reconstructions.
Cox regression analysis revealed that female gender (RR,
5.1; 95% CI, 1.8 to 7.9; P  .002) and renal insufficiency
(creatinine level, 1.6 mg/dL; RR, 6.6; 95% CI, 1.6 to
14.2; P  .01) were the only independent predictors of
decreased primary stent patency for all patients with LTI,
with control for the presence of all other risk factors (Table
IV).
Stratified univariate and multivariate analyses consider-
ing the patency of both iliac arteries (ie, not analyzing on a
unilateral iliac artery basis) revealed similar results. Female
gender was associated with a reduced primary stent patency
rate in patients with critical ischemia (RR, 5.0; 95% CI, 1.7
to 14.6; P  .003).
Although not statistically significant, women had an
increased risk of undergoing subsequent aortoiliac recon-
structions compared with men (39% versus 21%; RR, 2.3;
95% CI, 0.9 to 3.8; P .08). Limb salvage rates at 1, 3, and
5 years were 97%, 92%, and 92% for women and 100%, 98%,
and 98% for men. For all patients, limb salvage rate at 1, 3,
and 5 years was 98%, 96%, and 96%, respectively. Limb
salvage analyses with KM and log-rank test revealed a trend
toward decreased limb salvage in women (P  .06). One
operative (30-day) death occurred in a patient after a myo-
cardial infarction sustained 2 days after the operative pro-
cedure. Overall, long-term survival rate was 91% at 1 year,
87% at 3 years, and 79% at 5 years. No independent
predictors for limb salvage and long-term survival were
identified with multivariate analyses.
DISCUSSION
This study indicates that female gender and renal insuf-
ficiency are significant predictors of poor outcome after iliac
angioplasty and stenting in patients with LTI. Previous
observational studies on iliac artery angioplasty have in-
cluded patients with both disabling claudication and critical
ischemia.1-3 The proportion of patients with LTI, however,
has always been lower, and this difference has been even
more notorious in series on iliac stenting.4-8 Moreover, the
only randomized clinical trial on iliac angioplasty and stent-
ing included exclusively patients with intermittent claudi-
cation.21 Because few reports have focused on the use of
iliac angioplasty for the treatment of LTI, the effects of iliac
stenting on these particular patients have yet to be deter-
mined.11,12
We recently reported the effects of the anatomic loca-
tion of iliac stenting in both men and women with all grades
of ischemia.13 The presence of an EIA lesion was an inde-
pendent predictor of decreased primary stent patency in
women but not in men. Because in our practice an increas-
ing number of iliac angioplasty and stenting procedures are
now performed for LTI, and are frequently combined with
infrainguinal arterial reconstructions, we were uncertain as
to whether our previously identified predictors were rele-
vant for these particular patients. We thus considered it
important to review the effects of all risk factors on the
outcome of iliac artery angioplasty and stenting in patients
with LTI. In this study, therefore, our database was ana-
lyzed in a different way to prove another hypothesis: dis-
tinct and specific independent risk factors may influence the
outcome of iliac angioplasty and stenting in patients with
critical ischemia. The identification of these predictors is
clinically important because it may dictate the best treat-
Table III. Distribution, characteristics, and procedural
factors of 85 iliac angioplasty and stenting procedures for
critical ischemia comparing women and men
Women
(n  39)
Men
(n  46) P value
Iliac disease
Stenosis 32 (82%) 39 (85%) NS
Occlusion 7 (18%) 7 (15%) NS
TASC stratification of iliac
lesions
Type A 1 (3%) 14 (30%) .002*
Type B 22 (48%) 20 (51%) NS
Type C 16 (41%) 10 (22%) NS
Type D 2 (5%) 0 (0%) NS
Primary stent placement 9 (23%) 27 (58%) .002*
Poor runoff (score  5) 10 (25%) 4 (9%) .04*
Anatomic location of stenting
CIA 21 (54%) 28 (61%) NS
EIA 2 (5%) 4 (9%) NS
Both 16 (41%) 14 (30%) NS
*2 analysis.
NS, Not significant.
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ment for these patients. In this regard, we do believe that
stratified analyses are necessary to define specific risk factors
for different subgroups of patients, as emphasized by the
Ad Hoc Committee on Reporting Standards (SVS/
ISCVS).15 Although some risk factors for adverse outcome
may be known for a specific procedure, this does not mean
such factors affect all patients. For instance, we have found
in this study that, in addition to female gender, renal
insufficiency is also an independent predictor for primary
iliac stent failure, whereas the anatomic location of stenting
is not a significant risk factor for lesions associated with
critical ischemia.
As recognized by other authors, stratified analyses and
evaluation of subgroups of patients revealed evident differ-
ences in terms of outcome between the two gen-
ders.1,2,6,9,10 In a series with iliac angioplasty alone,
Johnston et al1 found a lower patency rate for women in the
subanalysis of external iliac stenosis. Smaller vessel size has
been suggested as a possible reason for decreased patency
rates in women, but this assumption has also been ques-
tioned in the literature because of inconsistent results.1-7 In
our study, vessel size was not an independent predictor for
primary stent failure and therefore did not account for the
adverse results observed in women. Moreover, the average
size of the EIA between men and women was not signifi-
cantly different, but yet, primary stent patency was reduced
in women.
In our previous study, EIA stenting was identified as an
independent predictor of reduced primary stent patency in
patients with both disabling claudication and critical isch-
emia.13 Of interest, the anatomic location of stenting was
not a significant risk factor for reduced primary stent pa-
tency in patients with critical ischemia. The fact that most
patients with EIA stenting underwent concomitant infrain-
guinal arterial reconstructions may in part explain the mi-
nor effect of this risk factor on the outcome of iliac artery
angioplasty and stenting in patients with LTI. However,
this assumption could not be proved statistically. Stratified
multivariate analyses, on the other hand, revealed that
women with LTI undergoing EIA stenting had the poorest
primary stent patency rates.
Despite a higher frequency of extensive iliac lesions
(TASC types C and D) and primary stent placement, and
poorer runoff in women, these associated risk factors failed
to explain their adverse outcome. In our study, stratified
multivariate analyses revealed that such variables were not
Women undergoing iliac angioplasty and stenting for LTI had significantly lower primary stent patency rates compared
with men (KM, log-rank test; P  .001). SE, Standard error.
Table IV. Independent predictors of primary stent
patency after iliac angioplasty and stenting for
critical ischemia*
Coefficient
Relative
risk† 95% CI P value
Female gender 1.631 5.1 1.8-7.9 .002
Renal insufficiency
(Cr  1.6)
1.899 6.6 1.6-14.2 .01
*Variables with P value  .25 in univariate analysis and those known to be
important and possible confounding factors were entered into multivariate
Cox regression models and selected with forward stepwise selection if P
value  .05 (P  .001 for models).
†Relative risk of reduced primary stent patency.
Cr, Creatinine level (mg/dL).
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independent predictors of decreased primary stent patency,
with control for the presence of all risk factors. Although
runoff scores were higher in women, most patients with
poor runoff underwent infrainguinal arterial reconstruc-
tions as adjunctive procedures to augment the effects of the
iliac intervention.
In recent studies, analysis of the endovascular treat-
ment of multisegment iliac occlusive disease has shown that
the presence of EIA disease is a significant predictor of poor
outcome.22,23 In these series, the indication for treatment
was disabling claudication in 60% of patients. These studies
show that more severe iliac occlusive disease does not
necessarily represent more severe chronic limb ischemia and
therefore patients with LTI should be considered sepa-
rately.
Although women had reduced primary stent patency
after iliac angioplasty and stenting, effective limb salvage
was feasible. Because all patients in this series were treated
for LTI, such a result is extremely favorable. Substantial
improvement in limb salvage was possible through diligent
surveillance and additional reconstructive procedures, an
approach that should be maintained to obtain optimal
results.
The current criteria prepared and revised by the Ad
Hoc Committee on Reporting Standards (SVS/ISCVS)
were followed in our study.15,16 However, an overestima-
tion of the influence of risk factors particular to those
patients who underwent more than one procedure could be
possible when basing the different analyses on the number
of lesions and procedures. Stratified analyses were obtained
including both iliac arteries (ie, data were not analyzed on a
unilateral iliac artery basis). These additional calculations,
considering the patient and not the stent as the unit of
study, revealed similar results: female gender was an inde-
pendent predictor of decreased primary stent patency.
In conclusion, women with LTI undergoing iliac artery
angioplasty and stent placement have a significantly re-
duced primary stent patency rate. Despite initial technical
success, these patients are at increased risk of long-term
stent failure. Patients with renal disease and critical limb
ischemia also have decreased primary stent patency rates.
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DISCUSSION
Dr Eugene M. Langan III (Greenville, SC). Dr Lumsden,
members and guests. Dr Timaran and colleagues again report their
data on iliac artery angioplasty and/or stenting. Their study fo-
cuses on patients with limb-threatening ischemia including both
rest pain and tissue loss. As would be expected, based on their
previous work, women had significantly reduced primary patency
rates. In this study, the majority of interventions were performed
by vascular surgeons in the operating room, a change from the
authors’ past reports. Of interest, 41% of procedures required an
additional open surgical revascularization to assist patency and
limb salvage.
I have two questions for Dr Timaran. First, were all these
endovascular procedures performed percutaneously? It has been
our experience that when a combined procedure will be required
for limb salvage these are performed at the same time with an open
arterial exposure.
Second, although a minority of your patients had complex iliac
lesions, most of which were in women, this had no statistical effect
on their outcome. It is also interesting that outflow did not
adversely affect your outcome in women. What are your thoughts
on these facts?
I would like to thank the association for the privilege of the
floor and Dr Timaran for an advance copy of his manuscript.
Dr Carlos H. Timaran. Thank you Dr Langan for your
comments and your insightful questions.
Actually one third of the patients underwent concurrent in-
frainguinal arterial reconstructions, and these procedures were
performed through an open approach. Sixty-seven percent of
patients were done percutaneously, although some of these pa-
tients required additional infrainguinal arterial reconstruction,
which was performed later on. Most of the procedures were
performed for TASC type B and C lesions. Only a few procedures
were performed for type D lesions, and these were actually patients
that were considered to be at high risk for surgical reconstruction.
We believe that the appropriate selection of patients is what is
important. I think this is why probably the severity of the iliac
lesions was not a predictor for primary stent failure in the multi-
variate analysis model. Most patients that had poor runoff under-
went additional infrainguinal arterial reconstruction. We think
because of this reason the effect of runoff on primary stent patency
was not as significant. We think that the infrainguinal reconstruc-
tion improves the outflow and in this way counteracts the effects of
a poor runoff.
Dr Alan Lumsden (Houston, Tex). Technically, when you
do a concurrent inflow procedure and then distal revascularization
in the operating room, one of my concerns is that transition point
between the distal external iliac artery and into the common
femoral artery. And how do you manage if the disease extends
down the external iliac artery and then requiring it to be clamped,
it means that you cannot extend the stent down across all the
disease because of fear of subsequently clamping it to perform the
inflow procedure. There is always this danger that you have this
untreated segment distal to the stent and proximal to your inflow
going down the leg. How do you handle that, or do you have any
tips on how we can prevent those kind of problems from arising?
Dr Timaran. Most lesions actually that extend from the
external iliac artery into the common femoral artery are actually
type C and D lesions, and we prefer to perform an open surgical
reconstruction for those patients. We have performed only a few
endovascular procedures for those types of lesions, and, yes, you
are right, this is a very difficult technical problem. Again, our
experience is limited because most of the patients are not at high
risk and undergo open surgical reconstruction.
Dr Lumsden. One technical tip is that when you have the
sheath in the groin, switch from clamping to endoluminal control.
If you put a balloon inside the stent in the distal external iliac
artery, then usually that gives you good visualization of as much of
the distal external iliac artery and so that if you have to do a
common femoral endarterectomy, you can go ahead and do it
without risk of clamping the stent.
Dr Ali AbuRahma (Charleston, WVa). I might have missed
this. Forgive me if you presented it but I did not get it. There is
always a debate whether the external iliac lesion has unfavorable
outcome when it comes to PTA stenting, and most of us have
always been told to stent these. We looked into this, and we
published our data a few months ago. We realized that it was not as
much the external iliac as the length of the lesion, so my question
to you is did you look at the length of the lesion and see whether
that was the impact? Secondly, did you undergo all these factors
you indicated to us that they were of significant P value? Did you
look into linear regression analysis to see if maybe one of them was,
for example, the length of the lesion?
Dr Timaran. We controlled for this factor—the length of the
lesion—and in our models this was not an independent predictor.
We do not know the reason. Probably our sample size is small and
we could have a type 2 error here. There was a trend to decreased
primary stent patency in patients with longer lesions, especially
those longer than 4 to 5 cm, but again this was not an independent
predictor in the final model.
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